Things like completed enrollment have more of an impact on PPS for companies that have partners or high institutional ownership. I see a typical bio run up in early 2016 leading up to the interim data. There is no reason to partner this late in the game prior to the data readout. I just don't see the upside at this point.
News 
Market Data 
Discover 
